Brain 

 Glioblastoma

A071102: A Phase II/III Randomized Trial of Veliparib or Placebo in Combination with Adjuvant Temozolomide in Newly Diagnosed Glioblastoma with MGMT Promoter Hypermethylation

For more information, contact Cheryl Patz, RN, OCN, CCRC, at 360-788-8238